LDL cholesterol (LDL-C) remains the primary focus for cardiovascular risk assessment in the U.S., but many patients who meet their target "LDL-C goal" still develop complications from atherosclerotic vascular disease and suffer from cardiovascular events. Register for this webinar and hear the latest on emerging cardiovascular risk assessment strategies involving the measurement of lipid particles.